[HTML][HTML] Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar, N Rajendra Prasad - Journal of …, 2022 - Springer
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …

Novel nanomedicines to overcome cancer multidrug resistance

Z Su, S Dong, SC Zhao, K Liu, Y Tan, X Jiang… - Drug Resistance …, 2021 - Elsevier
Chemotherapy remains a powerful tool to eliminate malignant cells. However, the efficacy of
chemotherapy is compromised by the frequent emergence of intrinsic and acquired …

[HTML][HTML] Emerging nano-based strategies against drug resistance in tumor chemotherapy

L Cao, Y Zhu, W Wang, G Wang, S Zhang… - … in bioengineering and …, 2021 - frontiersin.org
Drug resistance is the most significant causes of cancer chemotherapy failure. Various
mechanisms of drug resistance include tumor heterogeneity, tumor microenvironment …

[HTML][HTML] Role of nanotechnology in overcoming the multidrug resistance in cancer therapy: A review

SA Mir, L Hamid, GN Bader, A Shoaib, M Rahamathulla… - Molecules, 2022 - mdpi.com
Cancer is one of the leading causes of morbidity and mortality around the globe and is likely
to become the major cause of global death in the coming years. As per World Health …

Nanomedicines for combating multidrug resistance of cancer

YX Zhu, HR Jia, QY Duan, FG Wu - Wiley Interdisciplinary …, 2021 - Wiley Online Library
Chemotherapy typically involves the use of specific chemodrugs to inhibit the proliferation of
cancer cells, but the frequent emergence of a variety of multidrug‐resistant cancer cells …

[HTML][HTML] Nanodrug delivery in reversing multidrug resistance in cancer cells

S Kapse-Mistry, T Govender, R Srivastava… - Frontiers in …, 2014 - frontiersin.org
Different mechanisms in cancer cells become resistant to one or more chemotherapeutics is
known as multidrug resistance (MDR) which hinders chemotherapy efficacy. Potential …

Role of integrated cancer nanomedicine in overcoming drug resistance

AK Iyer, A Singh, S Ganta, MM Amiji - Advanced drug delivery reviews, 2013 - Elsevier
Cancer remains a major killer of mankind. Failure of conventional chemotherapy has
resulted in recurrence and development of virulent multi drug resistant (MDR) phenotypes …

Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology

H Choudhury, M Pandey, TH Yin, T Kaur, GW Jia… - Materials Science and …, 2019 - Elsevier
Multidrug resistance (MDR) is one of the key barriers in chemotherapy, leading to the
generation of insensitive cancer cells towards administered therapy. Genetic and epigenetic …

[HTML][HTML] Recent progress of novel nanotechnology challenging the multidrug resistance of cancer

C Zhang, X Zhou, H Zhang, X Han, B Li… - Frontiers in …, 2022 - frontiersin.org
Multidrug resistance (MDR) of tumors is one of the clinical direct reasons for chemotherapy
failure. MDR directly leads to tumor recurrence and metastasis, with extremely grievous …

[HTML][HTML] Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

X Sun, P Zhao, J Lin, K Chen, J Shen - Cancer Drug Resistance, 2023 - ncbi.nlm.nih.gov
Cancer is currently one of the most intractable diseases causing human death. Although the
prognosis of tumor patients has been improved to a certain extent through various modern …